Trending...
- Stockdale Capital Announces Four New Major Hires
- High-Growth Power Infrastructure Play Targets AI Boom: 1606 Corp. Executes Aggressive Texas Expansion Strategy: 1606 Corp. (Stock Symbol: CBDW) $CBDW
- As AI Accelerates Software Delivery, ThinkSys Introduces Zero Critical Bugs Guarantee
LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enochian Biosciences, Inc. ("Enochian" or "the Company") (NASDAQ: ENOB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's securities between January 17, 2018 and June 27, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before September 26, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Enochian co-founder Serhat Gumrukcu was not a licensed physician and did not hold a verifiable college degree of any type. The Company's science and technology, credited to Gumrukcu, were not likely to be legitimate. The Company overstated the commercial viability of its product pipeline. The Company's senior executives were aware of Gumrukcu's history including fraud. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Enochian, investors suffered damages.
More on The Californer
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Investors who purchased the Company's securities between January 17, 2018 and June 27, 2022, inclusive (the ''Class Period''), are encouraged to contact the firm before September 26, 2022.
If you are a shareholder who suffered a loss, click here to participate.
More on The Californer
- Governor Newsom calls FCC Chair Brendan Carr a "disgrace," says California will lead more antitrust enforcement to protect consumers from Trump's rising costs
- California doubles down on ocean health with historic investments, following landmark report findings
- New Dosio App Helps GLP-1 Users Track Shots, Side Effects, and Weight Trends
- Rachel Farris, CPA and Founder of Tax Stack AI, Featured on The Big 4 Transparency Podcast
- Compliance Alert: Maryland, Texas Regulate Use of Artificial Intelligence in Utilization Reviews
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Enochian co-founder Serhat Gumrukcu was not a licensed physician and did not hold a verifiable college degree of any type. The Company's science and technology, credited to Gumrukcu, were not likely to be legitimate. The Company overstated the commercial viability of its product pipeline. The Company's senior executives were aware of Gumrukcu's history including fraud. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Enochian, investors suffered damages.
More on The Californer
- When the Wrong Word Can Cost Everything, You Need a Legal Translation Partner You Can Actually Trust
- News you won't see on Fox News: California revoked over 280 hospice licenses, 300 more providers under investigation since Governor Newsom's hospice moratorium
- Colony Ridge Communities Celebrates Successful Soccer Season Kickoff with Families and Youth
- One Circle Foundation Launches Calm & Connected, a New Youth Mental Health Curriculum
- United Hotel Supply Rolls Out Upgraded PTAC & HVAC Solution for Hotels & Motels in the U.S
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com
Filed Under: Business
0 Comments
Latest on The Californer
- KeysCaribbean Offers 'Skip-the-Crowds' Savings With 15 Percent Off April Stays
- California: Governor Newsom announces appointments 3.23.2026
- Breaking the Civilian Barrier: ResuModAI Helps Veterans Translate Military Service into Job Offers in 60 Seconds
- Global Leaders Meet in Baku: The World Is Running Out of Time
- Long Beach Parks, Recreation and Marine to Offer Youth Summer Day Camps
- USFITC Extends International Defense Supply Capabilities with Sealing Component Delivery
- Supply & Demand Chain Executive Names Puga Sankara as Recipient of 2026 Pros to Know Award
- For Financial Literacy Month: Check out "TINA, TARA, TAPAS & TIARA" & "Better Than Expected Losses"
- Benchmark International Successfully Facilitated the Transaction Between LPAS, Inc. and Bluwatr
- TIME WASTED: The 2027 Releasing TV Show
- JetPipe Plumbing Brings Licensed, Specialized Plumbing Services to the San Francisco Bay Area
- AI Disruption Meets Marine Scale: Off The Hook YS, Inc. (N Y S E American: OTH) Targets Breakout Growth with NextBoat Launch and Aggressive Expansion
- Targeting the Billion-Dollar U.S. Countermeasure Market With AI-Driven Biodefense Platform: Lunai Bioworks (N A S D A Q: LNAI)
- A-One Janitorial Wins $152M AI Campus Contract — Meta, Microsoft, Google, and AWS
- New Global Standard for Transparency Across Critical Resources and Energy Markets: SMX (Security Matters) PLC (N A S D A Q: SMX)
- Forced Psychiatric Hospitalization Fails Vulnerable People: CCHR Urges Repeal Amid Rising U.S. Policies
- Surging Into High-Performance AI With $AMD Partnership, Patent Expansion, and Strengthened Balance Sheet: Avalon GloboCare Corp. (N A S D A Q: ALBT)
- Kiko Nation Launches Mobile App to Modernize Livestock Management and Digital Animal Registry
- NEW MANAGEMENT BOOK: Creating a Joy-Centric Culture
- Countrywide Rental Strengthens Waste Management Services Across Bankston Campuses